Two short approaches to the COVID-19 drug ?-D-N4-hydroxycytidine and its prodrug molnupiravir.

Persaud KE, Sahu RR, Neary MC, Kapdi AR, Lakshman MK. Two short approaches to the COVID-19 drug ?-D-N4-hydroxycytidine and its prodrug molnupiravir. Org Biomol Chem. 2024 01 24; 22(4):735-740.

View in: PubMed

subject areas

Antiviral Agents
Cytidine
Humans
Hydroxylamines
Prodrugs

authors with profiles

Mahesh Lakshman

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support